I agree that this site is using cookies. You can find further informations here.
X
Bellet, Meritxell
142  results:
Search for persons X
?
1

Impact of coadministration of proton-pump inhibitors and pa..:

Di Cosimo, Serena ; Pérez-García, José Manuel ; Bellet, Meritxell...
The Breast.  76 (2024)  - p. 103761 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Lutein..:

Jhaveri, Komal L. ; Bellet, Meritxell ; Turner, Nicholas C....
Clinical Cancer Research.  30 (2023)  4 - p. 754-766 , 2023
Link: https://doi.org/10.1158/..
 
?
3

Correction to: SEOM–GEICAM–SOLTI clinical guidelines in adv..:

Garcia-Saenz, Jose Angel ; Blancas, Isabel ; Echavarria, Isabel...
Clinical and Translational Oncology.  25 (2023)  9 - p. 2759-2759 , 2023
Link: https://doi.org/10.1007/..
 
?
4

SEOM–GEICAM–SOLTI clinical guidelines in advanced breast ca..:

Garcia-Saenz, Jose Angel ; Blancas, Isabel ; Echavarria, Isabel...
Clinical and Translational Oncology.  25 (2023)  9 - p. 2665-2678 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Circulating tumor DNA reveals complex biological features w..:

Prat, Aleix ; Brasó-Maristany, Fara ; Martínez-Sáez, Olga...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
6

Palbociclib with Fulvestrant or Letrozole in Endocrine-Sens..:

Di Cosimo, Serena ; Pérez-García, José Manuel ; Bellet, Meritxell...
The Oncologist.  28 (2022)  1 - p. 23-32 , 2022
Link: https://doi.org/10.1093/..
 
?
7

The oral selective estrogen receptor degrader GDC-0810 (ARN..:

Bardia, Aditya ; Mayer, Ingrid ; Winer, Eric...
Breast Cancer Research and Treatment.  197 (2022)  2 - p. 319-331 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Palbociclib Rechallenge for Hormone Receptor–Positive/HER-N..:

Albanell, Joan ; Pérez-García, José Manuel ; Gil-Gil, Miguel...
Clinical Cancer Research.  29 (2022)  1 - p. 67-80 , 2022
Link: https://doi.org/10.1158/..
 
?
9

Author Correction: High p16 expression and heterozygous RB1..:

Palafox, Marta ; Monserrat, Laia ; Bellet, Meritxell...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
10

High p16 expression and heterozygous RB1 loss are biomarker..:

Palafox, Marta ; Monserrat, Laia ; Bellet, Meritxell...
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
11

Oestrogen receptor activity in hormone-dependent breast can..:

Chic, Nuria ; Schettini, Francesco ; Brasó-Maristany, Fara...
eBioMedicine.  69 (2021)  - p. 103451 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuva..:

Gil-Gil, Miguel J. ; Bellet, Meritxell ; Bergamino, Milana...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
13

Personalized cancer therapy prioritization based on driver ..:

Mateo, Lidia ; Duran-Frigola, Miquel ; Gris-Oliver, Albert...
Genome Medicine.  12 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
14

The proapoptotic gene interferon regulatory factor-1 mediat..:

Wang, Shixiong ; Somisetty, Venkata S. ; Bai, Baoyan...
Oncogene.  39 (2020)  40 - p. 6300-6312 , 2020
Link: https://doi.org/10.1038/..
 
?
15

Palbociclib and ribociclib in breast cancer: consensus work..:

Bellet, Meritxell ; Ahmad, Faten ; Villanueva, Rafael...
Therapeutic Advances in Medical Oncology.  11 (2019)  - p. 175883591983386 , 2019
Link: https://doi.org/10.1177/..
 
1-15